Publicaciones científicas

62 Publicaciones científicas disponibles

  • COVID-19 and the brain: impact on nuclear medicine in neurology

    23 de julio de 2020 | Revista: European Journal of Nuclear Medicine and Molecular Imaging

    Silvia Morbelli  1   2 , Ozgul Ekmekcioglu  3 , Henryk Barthel  4 , Nathalie L Albert  5 , Ronald Boellaard  6 , Diego Cecchin  7 , Eric Guedj  8 , Adriaan A Lammertsma  6 , Ian Law  9 , Ivan Penuelas  10 , Franck Semah  11 , Tatjana Traub-Weidinger  12 , Elsmarieke van de Giessen  13 , Andrea Varrone  14 , Valentina Garibotto  15   16 , EANM Neuroimaging Committee


  • Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies

    28 de junio de 2019 | Revista: International Journal of Pharmaceutics

    Vairo C (1), Collantes M (2), Quincoces G (2), Villullas S (3), Peñuelas I  (4), Pastor M (3), Gil AG (5), Gainza E (3), Hernandez RM (6), Igartua M (6), Gainza G (7).

    (1) BioKeralty Research Institute AIE, Albert Einstein, 25-E3, 01510 Miñano, Araba, Spain; NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country (UPV/EHU), School of Pharmacy, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
    (2) Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (3) BioKeralty Research Institute AIE, Albert Einstein, 25-E3, 01510 Miñano, Araba, Spain.
    (4) Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain; Small Animal Imaging Research Unit, Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Pamplona, Spain.
    (5) Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain; Toxicology Unit, Drug Development Unit University of Navarra (DDUNAV), 31008 Pamplona, Spain.
    (6) NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country (UPV/EHU), School of Pharmacy, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain.
    (7) BioKeralty Research Institute AIE, Albert Einstein, 25-E3, 01510 Miñano, Araba, Spain


  • PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy

    6 de marzo de 2019 | Revista: Journal of Controlled Release

    Niu Z 1, Samaridou E (1), Jaumain E (2), Coëne J (2), Ullio G (2), Shrestha N (3), Garcia J (4), Durán-Lobato M (1), Tovar S (5), Santander-Ortega MJ (6), Lozano MV (6), Arroyo-Jimenez MM (6), Ramos-Membrive R (7), Peñuelas I (7), Mabondzo A (2), Préat V (3), Teixidó M (4), Giralt E (4), Alonso MJ (8).

    (1) Center for Research in Molecular Medicine and Chronic Diseases, IDIS research Institute, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
    (2) Service de Pharmacologie et d'Immunoanalyse, IBITECS, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.
    (3) Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, B-1200 Brussels, Belgium.
    (4) Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain.
    (5) Biomedical Research Group, Center for Research in Molecular Medicine and Chronic Diseases, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
    (6) Cellular Neuroanatomy, Molecular Chemistry of Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha, 02071 Albacete, Spain; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain.
    (7) Radiopharmacy Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, University Clinic of Navarra, 31008 Pamplona, Spain.
    (8) Center for Research in Molecular Medicine and Chronic Diseases, IDIS research Institute, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.


  • Mannosylated nanoparticles for oral immunotherapy in a murine model of peanut allergy

    5 de marzo de 2019 | Revista: Journal of Pharmaceutical Sciences

    Brotons-Canto A (1), Gamazo C (1), Martín-Arbella N (1), Abdulkarim M (2), Gumbleton M (2), Quincoces G (3), Peñuelas I (3), Irache JM (4).

    (1) NANO-VAC Research Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008, Pamplona, Spain.
    (2) School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, UK.
    (3) Radiopharmacy Unit, Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Spain.
    (4) NANO-VAC Research Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008, Pamplona, Spain.